Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Goldman Sachs boosts sentiment on Estée Lauder shares 💡
US OPEN: "Green" Start to the Week on Wall Street
OpenAI Announces Partnership with Broadcom. Company Shares Soar!
DE40: Europe's markets recovering from correction